Vaccinex Ownership

Over half of Vaccinex's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions.
Some institutional investors establish a significant position in pink sheets such as Vaccinex in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Vaccinex, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Vaccinex Pink Sheet Ownership Analysis

About 51.0% of the company outstanding shares are owned by institutional investors. The company recorded earning per share (EPS) of 7.42. Vaccinex had not issued any dividends in recent years. The entity had 1:14 split on the 20th of February 2024. Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D . Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. Vaccinex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.The quote for Vaccinex is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Maurice Zauderer at 585 271 2700 or visit https://www.vaccinex.com.

Vaccinex Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vaccinex insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vaccinex's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vaccinex insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Maurice Zauderer over six months ago
Acquisition by Maurice Zauderer of 1877 shares of Vaccinex at 8.21 subject to Rule 16b-3
 
Van Strydonck, Gerald E. over six months ago
Disposition of 3149 shares by Van Strydonck, Gerald E. of Vaccinex at 0.72 subject to Rule 16b-3
 
Maurice Zauderer over six months ago
Acquisition by Maurice Zauderer of 46153 shares of Vaccinex at 3.25 subject to Rule 16b-3
 
Elizabeth Evans over six months ago
Acquisition by Elizabeth Evans of 1341 shares of Vaccinex at 8.21 subject to Rule 16b-3
 
Jill Sanchez over six months ago
Disposition of tradable shares by Jill Sanchez of Vaccinex at 615.3 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 6711552 shares of Vaccinex at 0.3743 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 100 shares of Vaccinex at 4.51 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 2753 shares of Vaccinex at 4.92 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 3653 shares of Vaccinex at 4.6 subject to Rule 16b-3
 
Van Strydonck, Gerald E. over six months ago
Acquisition by Van Strydonck, Gerald E. of 2000 shares of Vaccinex at 1.3 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 11703 shares of Vaccinex at 4.72 subject to Rule 16b-3
 
Yanni Barbara over six months ago
Acquisition by Yanni Barbara of 53254 shares of Vaccinex at 1.12 subject to Rule 16b-3

Vaccinex Outstanding Bonds

Vaccinex issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vaccinex uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vaccinex bonds can be classified according to their maturity, which is the date when Vaccinex has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in Vaccinex Pink Sheet

If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance